Prognostic role of iodine values for gastric cancer after neoadjuvant chemotherapy: a strong independent prognostic factor

Prognostic role of iodine values for gastric cancer after neoadjuvant chemotherapy: a strong independent prognostic factor

PURPOSEWe aimed to systematically explore the value of iodine values calculated from dual-energy computed tomography (DECT) as potential prognostic factors for locally advanced gastric cancer (LAGC) patients undergoing neoadjuvant chemotherapy (NAC).METHODSEighty-five LAGC patients were examined usi...

Full description

Bibliographic Details
Main Authors:	Yang Zhang, Junfa Chen, Fei Yuan, Benyan Zhang, Bei Ding, Huan Zhang
Format:	Article
Language:	English
Published:	Galenos Publishing House 2022-09-01
Series:	Diagnostic and Interventional Radiology
Online Access:	http://www.dirjournal.org/archives/archive-detail/article-preview/prognostic-role-of-iodine-values-for-gastric-cance/53603

Similar Items

Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
by: Jian-Wei Xie, et al.
Published: (2021-07-01)

Predictive and prognostic value of EPIC1 in patients with breast cancer receiving neoadjuvant chemotherapy
by: Yaqian Xu, et al.
Published: (2020-07-01)

Aspartate β-Hydroxylase Serves as a Prognostic Biomarker for Neoadjuvant Chemotherapy in Gastric Cancer
by: Xuejun Gan, et al.
Published: (2023-03-01)

Prognostic Model of D2 Radical Gastrectomy Combined with Neoadjuvant Chemotherapy for Gastric Cancer
by: Wang G, et al.
Published: (2023-07-01)

Risk Factors and Prognostic Impact of Postoperative Complications in Patients with Advanced Gastric Cancer Receiving Neoadjuvant Chemotherapy
by: Hong Yu, et al.
Published: (2022-09-01)

Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
by: Özlem Özdemir, et al.
Published: (2022-04-01)

Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy
by: Cao Maria D, et al.
Published: (2012-01-01)

Clinical significance and prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients
by: Yang He, et al.
Published: (2023-01-01)

Evaluation of predictive and prognostic value of androgen receptor expression in breast cancer subtypes treated with neoadjuvant chemotherapy
by: Zhendong Shi, et al.
Published: (2023-04-01)

Predictive and prognostic value of ZEB1 protein expression in breast cancer patients with neoadjuvant chemotherapy
by: Ziping Wu, et al.
Published: (2019-03-01)

Lymph node ratio is a prospective prognostic indicator for locally advanced gastric cancer patients after neoadjuvant chemotherapy
by: Qi Jiang, et al.
Published: (2022-08-01)

Predictive and prognostic values of tumor infiltrating lymphocytes in breast cancers treated with neoadjuvant chemotherapy: A meta-analysis
by: Shiqi Li, et al.
Published: (2022-12-01)

Tumor Microenvironment Characterization in Breast Cancer Identifies Prognostic and Neoadjuvant Chemotherapy Relevant Signatures
by: Fei Ji, et al.
Published: (2021-10-01)

Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population
by: Agnieszka Pikuła, et al.
Published: (2022-04-01)

Distinct prognostic values of YAP1 in gastric cancer
by: Lan Yu, et al.
Published: (2017-04-01)

Prognostic value of a modified systemic inflammation score in breast cancer patients who underwent neoadjuvant chemotherapy
by: Cong Jiang, et al.
Published: (2022-12-01)

Prognostic value of systemic inflammation response index in hepatoblastoma patients receiving preoperative neoadjuvant chemotherapy
by: Chen Zheng, et al.
Published: (2023-10-01)

Prognostic value of differentiation status in gastric cancer
by: Fan Feng, et al.
Published: (2018-09-01)

Neoadjuvant chemotherapy for breast cancer: Pathologic response rates but not tumor size, has an independent prognostic impact on survival
by: Gilles Houvenaeghel, et al.
Published: (2024-02-01)

Predictive Factors and Prognostic Value of Pathologic Complete Response of Internal Mammary Lymph Nodes in Breast Cancer After Neoadjuvant Chemotherapy
by: ZHANG Weifang, et al.
Published: (2022-12-01)

High post‐chemotherapy TIL and increased CD4+TIL are independent prognostic factors of surgically resected NSCLC following neoadjuvant chemotherapy
by: Wenxiao Jia, et al.
Published: (2023-02-01)

Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery
by: Xiang-Bo Wan, et al.
Published: (2020-08-01)

The Sensitivity Prediction of Neoadjuvant Chemotherapy for Gastric Cancer
by: Juan Sun, et al.
Published: (2021-04-01)

Prognostic significance of adjuvant chemotherapy in patients with gastric neuroendocrine carcinoma
by: ZHANG Rihong, GUO Yu, LIANG Yun, CHEN Luohai, CHEN Jie, WANG Wei
Published: (2022-09-01)

Neoadjuvant chemotherapy weakens the prognostic value of the pathological tumor burden score for colorectal cancer liver metastases
by: Leen Liao, et al.
Published: (2023-09-01)

The Prognostic Value of Lymph Node Involvement after Neoadjuvant Chemotherapy Is Different among Breast Cancer Subtypes
by: Lucie Laot, et al.
Published: (2021-01-01)

Predictive and Prognostic Value of TRIM58 Protein Expression in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
by: Zheng YZ, et al.
Published: (2022-12-01)

The prognostic value of BRCA1 mRNA expression levels following neoadjuvant chemotherapy in breast cancer.
by: Mireia Margeli, et al.
Published: (2010-01-01)

Prognostic Autophagy-Related Genes of Gastric Cancer Patients on Chemotherapy
by: Xiaolong Liu, et al.
Published: (2021-10-01)

Characterization of the prognostic values of the family in gastric cancer
by: Chaoran Yu, et al.
Published: (2019-07-01)

Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator
by: Li Chen, et al.
Published: (2021-03-01)

Prognostic value of final pathological stage in colon adenocarcinoma after neoadjuvant chemotherapy: A propensity score-matched study
by: Meijuan Xiang, et al.
Published: (2022-10-01)

High Infiltration of CD68+/CD163− Macrophages Is an Adverse Prognostic Factor after Neoadjuvant Chemotherapy in Esophageal and Gastric Adenocarcinoma
by: Maria C. Svensson, et al.
Published: (2022-05-01)

The prognostic value of radiological and pathological lymph node status in patients with cervical cancer who underwent neoadjuvant chemotherapy and followed hysterectomy
by: Jianghua Lou, et al.
Published: (2024-01-01)

Clinical significance and prognostic value of receptor conversion in hormone receptor positive breast cancers after neoadjuvant chemotherapy
by: Libo Yang, et al.
Published: (2018-03-01)

Predictive and prognostic value of Matrix metalloproteinase (MMP) - 9 in neoadjuvant chemotherapy for triple-negative breast cancer patients
by: Ruo-Xi Wang, et al.
Published: (2018-09-01)

Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease
by: Jing Li, et al.
Published: (2017-08-01)

The relationship between gastric microbiome features and responses to neoadjuvant chemotherapy in gastric cancer
by: Peng Zhang, et al.
Published: (2024-04-01)

Evaluation of the prognostic value of CBXs in gastric cancer patients
by: Mengya He, et al.
Published: (2021-06-01)

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.
by: Yuqin Ding, et al.
Published: (2020-01-01)